Book Appointment
Accessibility
Font Size
A
Grey Scale
Donate

Projects

Home / Projects / A Phase 3, Randomize Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis

A Phase 3, Randomize Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis

Project Description

Phase 3 oral cladribine study in Myasthenia Gravis – A passe 3 randomised, double -blind, placebo-controlled trail assessing oral cladribine in generalised myasthenia gravis 

Project Duration

2025 - 2027

Project Lead

Dr. G.R.K. Sarma

Authors

Dr. G.R.K Sarma Dr. Raghunandan Nadig Dr. Sonia Shivde Dr. Akshata Huddar

Project Status

ongoing

Project Type

Drug Study

Book